SPRO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Spero Therapeutics Inc

Watchlist Manager

Watchlist

Price: 2.26 USD 11.88% Market Closed

Market Cap: $130.9m

	Spero Therapeutics Inc NASDAQ:SPRO	US
A	Anheuser-Busch Inbev SA VSE:ABIN	BE
	Mitsubishi Corp F:MBI0	JP
A	Axis Bank Ltd F:UZC	IN
	Five Below Inc NASDAQ:FIVE	US
B	Bank of Montreal F:BZZ	CA
K	Kirby Corp F:KIY	US
	Aviva PLC F:GU81	UK
	COPT Defense Properties NYSE:CDP	US
	Guotai Junan Securities Co Ltd F:153A	CN
	Comstock Inc F:GSP0	US

Profitability Summary

Spero Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Healthy Operating Margin

11%

Negative 3Y Average Operating Margin

-45%

Operating Margin is Increasing

-56% > 11%

Healthy Net Margin

13%

Negative 3Y Average Net Margin

-42%

Net Margin is Increasing

-50% > 13%

Negative Free Cash Flow Margin

-19%

Negative 3Y Average Free Cash Flow Margin

-26%

Declining Free Cash Flow Margin

14% > -19%

Positive ROE

16%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-43%

ROIC is Increasing

-172% > 18%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.